Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy

BACKGROUND: The objective of this study was to explore the prognostic value of the Bone Scan Index (BSI) obtained at the time of diagnosis in a group of high-risk prostate cancer patients receiving primary hormonal therapy. METHODS: This was a retrospective study based on 130 consecutive prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaboteh, Reza, Damber, Jan-Erik, Gjertsson, Peter, Höglund, Peter, Lomsky, Milan, Ohlsson, Mattias, Edenbrandt, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570487/
https://www.ncbi.nlm.nih.gov/pubmed/23384286
http://dx.doi.org/10.1186/2191-219X-3-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570487/
https://www.ncbi.nlm.nih.gov/pubmed/23384286
http://dx.doi.org/10.1186/2191-219X-3-9

Ejemplares similares